MedTrace Logo

Prevalence of Depression and Anxiety Among Breast Cancer Patients

NCT05011409 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 162

Last updated 2022-03-25

No results posted yet for this study

Summary

Depression and anxiety in patients with breast cancer is serious comorbidity that affects the quality of life for patients, and their survival rates as they have poorer health outcomes. Furthermore, patients' high psychological burden is linked to higher healthcare costs. The investigation of the depression and anxiety symptoms prevalence among newly diagnosed breast cancer patients will help to navigate the health policy adjustment and psycho-social support system requirements. This study aims to investigate the prevalence of depression and anxiety symptoms among newly diagnosed breast cancer patients in Almaty, Kazakhstan, and associated risk factors.

Conditions

Sponsors & Collaborators

  • University of Malaya

    collaborator OTHER

  • Kazakh Medical University of Continuing Education

    lead OTHER

Principal Investigators

  • Indira A Karibayeva, MPH · Kazakh Medical University of Continuing Education

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-17
Primary Completion
2022-02-21
Completion
2022-03-10

Countries

  • Kazakhstan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05011409 on ClinicalTrials.gov